SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
17-May-24 7:09 PM View: | Acelyrin, Inc. (SLRN) | 15-May-24 | Payment of Exercise | 10,230 | $4.47 | $45,728.10 | (8%) 120.97K to 110.74K | |
18-Aug-23 6:52 PM View: | Acelyrin, Inc. (SLRN) | 16-Aug-23 | Grant | 114,676 | -- | -- | 2294% 5.0K to 119.68K | |
11-May-23 8:58 PM View: | Acelyrin, Inc. (SLRN) | 09-May-23 | Purchase | 5,000 | $18.00 | $90,000.00 | 100% 0 to 5.0K | |
07-Sep-22 7:31 PM View: | Zymergen Inc. (ZY) | 02-Sep-22 | Sale | 3,410 | $2.21 | $7,536.10 | (1%) 301.84K to 298.43K | |
04-Aug-22 5:36 PM View: | Zymergen Inc. (ZY) | 02-Aug-22 | Sale | 3,094 | $2.61 | $8,083.07 | (1%) 304.93K to 301.84K | |
07-Jul-22 4:54 PM View: | Zymergen Inc. (ZY) | 05-Jul-22 | Sale | 2,924 | $1.32 | $3,866.41 | (< 1%) 307.86K to 304.93K | |
06-Jun-22 7:30 PM View: | Zymergen Inc. (ZY) | 02-Jun-22 | Sale | 2,939 | $1.68 | $4,930.47 | (< 1%) 310.79K to 307.86K | |
04-May-22 6:17 PM View: | Zymergen Inc. (ZY) | 02-May-22 | Sale | 3,206 | $1.79 | $5,739.70 | (1%) 314.0K to 310.79K | |
15-Mar-22 6:41 PM View: | Zymergen Inc. (ZY) | 11-Mar-22 | Grant | 217,000 | -- | -- | 224% 97.0K to 314.0K | |
28-Oct-21 8:18 PM View: | Zymergen Inc. (ZY) | 26-Oct-21 | Grant | 97,000 | -- | -- | 100% 0 to 97.0K | |
10-Apr-19 4:33 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 09-Apr-19 | Payment of Exercise | 3,674 | $36.85 | $135,387.00 | (5%) 70.06K to 66.39K | 39% |
27-Mar-19 5:18 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 26-Mar-19 | Grant | 10,000 | -- | -- | 17% 60.06K to 70.06K | |
08-Feb-19 4:25 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 06-Feb-19 | Grant | 17,063 | -- | -- | 40% 43.0K to 60.06K | |
09-Apr-18 8:14 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 09-Apr-18 | Grant | 42,500 | -- | -- | 100% 0 to 42.5K | |
17-Mar-17 5:28 PM View: | Sunrun Inc. (RUN) | 15-Mar-17 | Grant | 131,000 | -- | -- | 67% 196.61K to 327.61K | |
10-Nov-16 9:07 PM View: | Sunrun Inc. (RUN) | 08-Nov-16 | Grant | 87,100 | -- | -- | 80% 109.51K to 196.61K |